Deoxyribonucleic Acid (DNA) Ploidy and Proliferative Characteristics of Metastatic Squamous Cell Carcinoma Determined by Flow Cytometric Analysis

background : The deoxyribonucleic acid (DNA) index and the proliferative index (the fraction of cells in the S phase) can be independent prognostic indicators of the biologic aggressiveness of certain malignant neoplasms. objective : To determine whether the DNA index or proliferative index could pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of Dermatologic Surgery and Oncology 1992-11, Vol.18 (11), p.957-960
Hauptverfasser: PAPPAS, ALEX A., MANERS, ANN W., OWENS, REBECCA B., THOMPSON, JENNIFER R., KING, JOHN C., DINEHART, SCOTT M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:background : The deoxyribonucleic acid (DNA) index and the proliferative index (the fraction of cells in the S phase) can be independent prognostic indicators of the biologic aggressiveness of certain malignant neoplasms. objective : To determine whether the DNA index or proliferative index could predict metastases in cutaneous squamous cell carcinoma. methods : Nineteen different metastases from 15 patients with primary cutaneous squamous cell carcinoma (SCC) were reviewed, graded, and had DNA proliferative indexing performed by fluorescent activated cytometry. A control group of 13 patients with primary cutaneous SCC without metastases were studied in a similar manner. results : No significant difference between the metastatic and the nonmetastatic SCC groups for either DNA index or proliferative index (non‐paired t‐test) was observed. No correlative association with histologic grading with DNA index or proliferative index was observed for either group. conclusion : We conclude that aneuploidy and S‐phase fraction by fluorescent activated cytometry are not significant predictors of potential metastases in cutaneous squamous cell carcinoma. J Dermatol Surg Oncol 1992;18:957–960.
ISSN:0148-0812
1524-4725
2374-846X
DOI:10.1111/j.1524-4725.1992.tb02767.x